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Abstract
Objective: The Lung is one of the most radiosensitive organs of the body. The infiltration of macrophages and lymphocytes 
into the lung is mediated via the stimulation of T-helper 2 cytokines such as IL-4 and IL-13, which play a key role in the 
development of fibrosis. It is likely that these cytokines induce chronic oxidative damage and inflammation through the 
upregulation of Duox1 and Duox2, which can increase the risk of late effects of ionizing radiation (IR) such as fibrosis and 
carcinogenesis. In the present study, we aimed to evaluate the possible increase of IL-4 and IL-13 levels, as well as their 
downstream genes such as IL4ra1, IL13ra2, Duox1, and Duox2.  
Materials and Methods: In this experimental animal study, male rats were divided into 4 groups: i. Control, ii. Melatonin-
treated, iii. Radiation, and iv. Melatonin (100 mg/kg) plus radiation. Rats were irradiated with 15 Gy 60Co gamma rays and 
then sacrificed after 67 days. The expressions of IL4ra1, IL13ra2, Duox1, and Duox2, as well as the levels of IL-4 and IL-13, 
were evaluated. The histopathological changes such as the infiltration of inflammatory cells, edema, and fibrosis were also 
examined. Moreover, the protective effect of melatonin on these parameters was also determined.         
Results: Results showed a 1.5-fold increase in the level of IL-4, a 5-fold increase in the expression of IL4ra1, and 
a 3-fold increase in the expressions of Duox1 and Duox2. However, results showed no change for IL-13 and no 
detectable expression of IL13ra2. This was associated with increased infiltration of macrophages, lymphocytes, and 
mast cells. Melatonin treatment before irradiation completely reversed these changes.                  
Conclusion: This study has shown the upregulation of IL-4-IL4ra1-Duox2 signaling pathway following lung irradiation. It 
is possible that melatonin protects against IR-induced lung injury via the downregulation of this pathway and attenuation of 
inflammatory cells infiltration.
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Introduction
Clinical evidence has shown that more than half of 
patients with cancers undergo radiotherapy during their 
course of disease treatment. Normal tissue toxicity is 
a major limiting factor for tumor control, leading to 
tumor recurrence and various side effects which affect 
the quality of life in treated patients (1). Exposure of 
both normal and tumor cells to ionizing radiation (IR) 
triggers the production of free radicals such as reactive 
oxygen species (ROS) and nitric oxide (NO). In addition 
to direct detrimental effects of IR, these molecules can 
further amplify damage to cells, resulting in DNA damage 
and cell death which cause several side effects in the 
irradiated area (2). The lung is one of the sensitive organs 
of the human body to the toxic effects of IR. The high 
radiosensitivity of the lung limits the applied radiation 
dose for tumor eradication. As non-small cell lung 
carcinoma (NSCLC) has high resistance to radiotherapy, 
this results in increased probability of tumor relapses (3). 
Therefore, to overcome these tumor cells, there is a need 
for a high dose of IR. However, this may be associated 
with an increased risk of pneumonitis and fibrosis (4). In 
recent years, there have been significant improvements in 
radiotherapy in the delivery of a more precise radiation 
dose to the tumor volume while sparing normal tissues. 
However, acute and late normal tissue damage remain an 
important factor (5). In the lung, radiation-induced side 
effects such as inflammatory responses (pneumonitis) 
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and fibrosis are the most common limiting factors (6). 
Currently, there are no appropriate strategies to overcome 
these complications completely.  
Fibrosis is a process resulting from excessive accumulation 
of collagen due to differentiation of fibroblasts. It is associated 
with tissue remodeling and affects normal physiological 
functions (7). Fibrosis and inflammation in some crucial 
organs such as lung, heart, and gastrointestinal system may 
threaten patients’ life (8). Experimental and clinical studies 
have shown that abnormal increases in the levels of some 
cytokines such as TGF-β, IL-1, IL-4, IL-13, TNF-α, etc., have 
a central role in the development of fibrosis and inflammation 
(9, 10). The inhibition of some cytokines such as TGF-β and 
TNF-α has been most widely studied for the amelioration 
of fibrosis and inflammation (11). In addition to TGF-β, in 
recent years, some studies have proposed that IL-4 and IL-13 
signaling pathways play a key role in the fibrosis process (12). 
These cytokines trigger the expression of duox1 and duox2 
through the upregulation of their cognate receptors on cells, 
which mediate continuous ROS production and stimulation 
of fibrosis (13). It has been shown that the upregulation of 
these cytokines may induce the infiltration of macrophages 
and maintenance of inflammation (14). As pro-oxidant 
enzymes such as Duox1, Duox2, NOX1-5, iNOS, and COX-
2 play a key role in continuous ROS production and damage 
to the normal function of organs, suggesting that targeting of 
these enzymes/genes can help manage normal tissue toxicity 
during radiotherapy (15).    
Treatment with some adjuvants for sensitization of tumor 
cells or protection of normal tissue cells is one of the most 
interesting topics in radiation biology. Melatonin is a 
natural body hormone that regulates circadian rhythm, as 
well as several mechanisms in the body such as antioxidant 
enzyme activity (16). In addition, melatonin has a potent 
interrelationship with immune system cells (17). In response 
to radiation, melatonin has shown the ability to protect normal 
tissues through scavenging of free radicals, stimulation of 
antioxidant enzymes, as well as anti-inflammatory effects 
(18, 19). Melatonin has also shown an ability to ameliorate 
radiation or chemotherapy-induced fibrosis in various 
organs such as the lung, heart, and others (20). In this study, 
we examined the effect of pre-treatment with melatonin on 
the development of fibrosis and histopathological damages 
following irradiation. Also, we evaluated the possible role of 
melatonin in alleviating increased levels of IL-4 and IL-13, as 
well as downstream genes such as Duox1 and Duox2 that are 
involved in late effects of IR. 
Materials and Methods
Experimental design
Melatonin was provided (Merck, Germany) and 
dissolved in 20% ethanol at a concentration of 20 mg/
ml. 1 ml of the prepared solution (100 mg/kg) was 
administered to each rat via intraperitoneal injection (18). 
For this Interventional-experimental study, twenty healthy 
adult male Wistar rats (200 ± 20 g) were purchased from 
the Razi Institute, Tehran, Iran. The procedure of this 
study was in accordance with the ethical laws for animal 
care provided by Kashan University of Medical Sciences, 
Kashan, Iran. All animals were housed in suitable conditions, 
including temperature and humidity (23 ± 2˚C and 55%, 
respectively). They were kept under the same light/dark 
cycle to prevent any effect of light/dark on basal levels of 
melatonin in different groups (light 8:00 AM to 8:00 PM 
and dark 8:00 PM to 8:00 AM). Twenty rats were randomly 
divided into 4 groups (5 rats in each), group 1: control, group 
2: melatonin-treated, group 3: radiation, group 4: melatonin-
treated+radiation. Melatonin was administered orally 30 
minutes before irradiation. Irradiation was performed using 
a 60Co source (15 Gy to the whole lung) (21). Sixty-seven 
days after irradiation, rats were anesthetized, sacrificed, and 
their lung tissues were extracted. The ventricles were fixed in 
10% normal buffer formalin while the auricles were frozen 
at -80˚C for real-time polymerase chain reaction (PCR) and 
ELISA.  
Real-time polymerase chain reaction
Total mRNA was isolated from frozen lung tissue of all 
groups using TRIzol Reagent (GeneAll, South Korea) while 
cDNA template was synthesized using cDNA synthesis Kits 
(GeneAll, South Korea) according to the manufacturer’s 
instructions. Pgm1 was used as an internal control while the 
other primers were designed using the Gene runner software 
and NCBI BLAST tool. Real-time PCR was performed using 
Corbett’s RT PCR (Qiagen, USA). The primer sequences are 
shown in Table 1. Real-time PCR efficiency for all mentioned 
genes in Table 1 was determined using the slope of linear 
regression as described by Pfaffl (22). Five samples in each 
group were run in duplicates.   
Table 1: Forward and reverse primer sequences used in this study
Gene Sequence primer (5ˊ-3ˊ)
IL-4r1 F: GAGTGAGTGGAGTCCCAGCATC
R: GCTGAAGTAACAGGTCAGGC 
IL- 13ra2 F: TCGTGTTAGCGGATGGGGAT
R: GCCTGGAAGCCTGGATCTCTA 
Duox1 F: AAGAAAGGAAGCATCAACACCC
R: ACCAGGGCAGTCAGGAAGAT
Duox2 F: AGTCTCATTCCTCACCCGGA 
R: GTAACACACACGATGTGGC
Pgm1 F: CATGATTCTGGGCAAGCACG
R: GCCAGTTGGGGTCTCATACAAA
ELISA
The levels of IL-4 and IL-13 cytokines were detected by 
the IL-4 and IL-13 ELISA kits (Zellbio, Germany) based 
on the manufacturer’s instructions. 
Pathological study
Fixed lung tissues were sectioned at 5-micron sections 
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and then stained with hematoxylin and eosin (H&E) for 
general tissue characterization. Masson’s trichrome staining 
(MTC) was also performed for the detection of collagen 
accumulation. The infiltration of mast cells was evaluated 
using Giemsa staining. All histopathological studies were 
performed at the Pathology Unit, Imam Khomeini Hospital, 
Tehran, Iran, with the aid of a light microscope.
Statistical analysis
All statistical analyses were performed using IBM SPSS 
statistics for windows, version 24.0 (IBM Corp., Armonk, 
NY, USA). The statistical significance (P<0.05) of mean ± 
SD for histopathological and ELISA were analyzed using the 
ANOVA test followed by post hoc Tukey’s HSD. Furthermore, 
the expression of genes was analyzed using t test. 
Results
ELISA 
Results showed that irradiation caused a significant 
increase in the level of IL-4 (702 ± 102) compared to 
the control group (469 ± 89, P<0.05). Treatment with 
melatonin before irradiation led to a significant decrease 
in IL-4 (372 ± 124) compared to the radiation group 
(P<0.05). Treatment with melatonin alone did not cause 
any significant change. Results also showed no significant 
change in the level of IL-13 for all groups (Fig.1).
Fig.1: Results of changes in the levels of IL-4 and IL-13 following irradiation 
with gamma rays and treatment with melatonin (MLT). A. IL-4 and B. IL-
13. a; Significant compared to control and b; Significant compared to 
radiation (Rad), ANOVA Tukey’s HSD post hoc, P<0.05.  
Real-time polymerase chain reaction
Irradiation of lung tissues was associated with a significant 
elevation in IL4ra1 compared to the control group (5.21 ± 0.92 
folds, P<0.05). When rats were treated with melatonin before 
exposure to IR, the expression of IL4ra1 was significantly 
decreased compared to the radiation group (2.60 ± 0.70 
folds, P<0.05). Results showed no detectable expression 
for IL13ra2. The expression of Duox1 gene was elevated 
following exposure to radiation (3.18 ± 0.57 folds, P<0.05). 
When rats were treated with melatonin before exposure to 
IR, the expression of Duox1 was significantly attenuated 
compared to the radiation group (2.60 ± 0.70, P<0.05). 
Results of Duox2 gene expression showed that irradiation 
caused an increase in its expression in comparison with the 
control group (2.95 ± 0.51 folds, P<0.001). Treatment with 
melatonin led to a significant reduction in Duox2 expression 
(1.21 ± 0.25 folds compared to control) compared to the 
radiation group (P<0.01, Fig.2). 
Fig.2: The expression of IL4ra1, Duox1 and Duox2 following irradiation or 
melatonin treatment before irradiation in lung tissues of rats. A. IL4ra1, B. 
Duox1, and C. Duox2. a; Significant compared to control and b; Significant 
compared to radiation (Rad), ANOVA followed by Tukey’s HSD post hoc, 
P<0.05. 
A
B
C
A
B
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Histopathological assay
Histopathological evaluation showed mild fibrosis in 
the radiation group. However, this reversed completely 
when melatonin was administered before irradiation. 
Also, results showed severe infiltration of macrophages 
and lymphocytes but not neutrophils. Irradiation led 
to severe alveolar thickening, as well as mild vascular 
thickening. Results for edema and thrombosis did not 
show any significant change. Treatment with melatonin 
could significantly reverse all these changes (Figs.3-5, 
Table 2).  
Table 2: Results of lung irradiation and the protective effect of melatonin
Variable Control Melatonin-treated Radiation Radiation+Melatonin  
Macrophage infiltration 0.25 ± 50 0.25 ± 50 2.66 ± 0.57a 0.80 ± 0.83b
Lymphocyte infiltration 1.00 ± 0.80 0.50 ± 0.57 3.00 ± 00a 0.60 ± 0.54b
Mast cell infiltration 0.00 ± 00 1.00 ± 50 4.00 ± 00a 3.50 ± 0.50
Neutrophil infiltration 0.50 ± 0.57 0.50 ± 0.57 0.00 ± 00 0.60 ± 0.54
Alveolar thickness 0.25 ± 50 0.25 ± 50 2.00 ± 1.00a 0.20 ± 0.44b
Vascular thickness 0.00 ± 00 0.00 ± 00 1.00 ± 00a 0.00 ± 00b
Edema and thrombosis 0.00 ± 00 0.00 ± 00 1.00 ± 0.57 0.00 ± 00
Fibrosis Absent Absent Mild Absent 
Results were scored from 0-3 as 0; Normal, 1; Mild, 2; Severe, 3; Very severe, a; Significant compared to control group, and b; Significant compared to 
radiation group. Data are presented as mean ± SD.
Fig.3: Histopathological investigation of the protective effect of melatonin on radiation-induced lung injury. Control and melatonin groups: no infiltration 
of macrophages and lymphocytes, as well as normal vascular and alveolar thickening, radiation: severe infiltration of macrophages and lymphocytes, as 
well as vascular thickening, while alveolar thickening mildly changed. A. Control; B. Melatonin, C. Radiation, D. Radiation+Melatonin (H&E staining ×100). 
A B
C D
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Fig.4: Results of trichrome staining showed a mild collagen deposition, while treatment with melatonin completely reversed collagen deposition. A. 
Control, B. Melatonin, C. Radiation, and D. Radiation+Melatonin (Masson’s Trichrome staining ×100).
Fig.5: Infiltration of mast cells following irradiation of lung tissues in rats. The administration of melatonin before irradiation could not significantly 
attenuate mast cell infiltration. A. Control, B. Melatonin, C. Radiation, and D. Radiation+Melatonin (Giemsa staining ×100).
A B
C D
A B
C D
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Discussion
The aim of our study was to evaluate changes in the levels 
of two important pro-fibrotic cytokines and downstream 
pro-oxidant genes such as Duox1 and Duox2. Moreover, 
we detected the possible modulatory effect of melatonin 
on the changes in the level of these factors. In the present 
study, we revealed that irradiation of rats’ chest led to a 
significant increase in the expression of IL4ra1, Duox1, 
and Duox2 genes. ELISA results showed that the level of 
IL-4 was increased significantly.
In contrast to IL-4, results suggest that irradiation of 
lung tissue did not cause any significant change in the 
level of IL-13. Moreover, real-time PCR results showed 
no detectable expression of IL13ra2. Probably, the 
upregulation of Duox1 was mediated by other signaling 
pathways, not by IL13ra2. A study has shown that, in 
addition to IL-13, Duox1 can be upregulated through 
IL-4 (23).  There is a possibility that IL-4 upregulates 
both Duox1 and Duox2 gene expressions through the 
stimulation of IL4ra1, while IL-13 is not involved in this 
pathway. There is also a possibility of the involvement of 
other cytokines such as IFN-γ (24, 25). Our results are in 
agreement with a study by Groves et al. (26) which showed 
that IL-4 is involved in the maintenance of macrophages 
and lung injury following irradiation. However, this study 
proposed that the development of fibrosis may be induced 
by other immune mediators but not IL-4. By contrast to 
our results, Chung et al. (14) reported that after exposure 
to IR, increased the level of IL-13 but not IL-4 was 
responsible for the development of lung injuries such as 
macrophage infiltration and fibrosis. They showed that 
IL-13 deficiency could reverse lung injury and reduce the 
expression of genes involved in fibrosis such as TGF-β, 
matrix metalloproteinase-2 (MMP-2), and MMP-3. 
However, this study differed from ours in the sense that 
they used wild-type c57BL/6NcR mice and a longer time 
of evaluation.
As earlier mentioned, the lung is one of the most critical 
organs for the detrimental effects of IR. It has been reported 
that the long-term exposure of the lung to radiotherapy 
due to cancer therapy or iodine therapy for thyroid cancer 
with metastasis can cause death via pneumonitis or 
fibrosis (27). In addition to clinical importance for cancer 
therapy, lung injury may appear following accidental 
exposure to IR. In this situation, lung late effects may 
appear following non-uniform whole body exposure or 
inhalation of radionuclides (28).  As the development of 
lung injury may take a long time to appear, a knowledge 
of the mechanisms involved in radiation-induced 
pneumonitis and fibrosis can help better management of 
them. Although most studies have detected the elevated 
level of TGF-β associated with radiation fibrosis, some 
studies suggest the greater importance of IL-4. It has been 
proposed that IL-4 plays a central role via the stimulation 
of other pro-inflammatory and pro-fibrotic cytokines 
(10). Infiltration of inflammatory cells including 
macrophages and lymphocytes in irradiated tissues is the 
source of increased release of IL-4. The accumulation 
of macrophages and lymphocytes and elevated levels of 
inflammatory cytokines promote ROS and NO through 
the stimulation of reduction/oxidation interactions (29). 
Increased oxidative injury induces a higher degree of 
inflammation and fibrosis in a positive feedback loop that 
could finally lead to death (28). 
Histopathological evaluation showed that irradiation 
of the lung led to severe infiltration of mast cells, 
macrophages, and lymphocytes, but not neutrophils. 
This suggests that neutrophil infiltration is involved 
in late effects of lung injury by IR. Moreover, the 
histological findings showed mild fibrosis, alveolar, and 
vascular thickening. Except for mast cell infiltration, 
all other pathological changes following exposure to IR 
were alleviated when melatonin was administered 30 
minutes before irradiation. Also, melatonin could blunt 
the upregulation of IL-4 and downstream signaling in 
IL4ra1 and Duox2. Since macrophages are the main 
source for the secretion of IL-4 during pneumonitis or 
fibrosis, it seems that the upregulation of IL-4 signaling 
after irradiation, as well as the downregulation of that in 
response to melatonin pretreatment prior to irradiation, is 
responsible for modulating the infiltration of macrophages. 
Regarding IL4ra1 and Duox2 can promote continuous 
ROS production, it is possible that IL-4 signaling plays a 
key role in radiation-induced fibrosis and vascular injury 
in the lung. Melatonin treatment before irradiation could 
reverse the upregulation of these genes completely.  
Previous studies have shown that melatonin has the 
ability to reduce radiation injury via the modulation 
of several signaling pathways. Melatonin is an FDA-
approved drug which has a peak time of absorption up to 40 
minutes and a half-life of 1-2 hours (30, 31). Therefore, its 
administration between 30-60 minutes before exposure to 
radiation is a common method for radiobiological studies. 
Melatonin has shown potent anti-inflammatory effects 
via the prevention of radiation-induced DNA damage 
and cell death (32). Melatonin can also elevate DNA 
repair capacity to mitigate cell death (19). By means of 
the inhibition of Toll-like receptors (TLRs), transcription 
factors, pro-oxidant enzymes, as well as pro-fibrotic and 
pro-inflammatory cytokines melatonin attenuates redox 
activity and relieves late effects of IR (20, 33). As a result 
of these properties, melatonin is appropriate for radiation 
countermeasure, protection, and mitigation of lung injury 
by IR (34).  
Conclusion 
Results of this study showed that irradiation of rats’ lung 
led to a significant increase in the level of IL-4 and pro-
oxidant genes such as Duox1 and Duox2. However, we 
did not observe any significant increase in the level of IL-
13, as well as the expression of IL13ra2. This could be an 
indication that radiation induces lung inflammation and 
fibrosis via the upregulation of IL-4 but not IL-13. This 
suggests that the infiltration of macrophages plays a key 
role in the stimulation of IL-4 and its downstream genes. 
In addition, we showed that melatonin administration 
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before irradiation reversed the infiltration of macrophages 
and lymphocytes, as well as the upregulation of IL-4, 
IL4ra1, Duox1, and Duox2.  
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